stock logo

Nippon AMC - NETF Pharma

PHARMABEES

₹23.12-₹0.24 (-1.03%) TodayLast updated on 04 Nov, 2024 | 15:55 IST

Nippon AMC - NETF Pharma Chart

Please wait...
  • Fund overview
  • Returns
  • Composition
  • More

Fund overview

About
arrow
Open
₹23.36
Close
₹23.36
Volume
36,80,783
Avg. traded
₹23.02
Circuit range
₹18.49 - ₹27.74
Day range
₹22.84 - ₹23.57
Year range
₹15.11 - ₹24.53
AUM
₹851.53 Cr

Managers

Himanshu Mange
Launch Date
06 Jul 2021
Nippon AMC - NETF Pharma

About Nippon India Nifty Pharma ETF

  • The Nippon India Nifty Pharma ETF is an open-ended mutual fund offered by Nippon India Mutual Fund.
  • The scheme primarily invests in pharma stocks.
  • Nippon India Nifty Pharma ETF was launched on July 2, 2021.
  • The ETF has assets under management (AUM) at ₹706.41 crore as of July 31.
  • Himanshu Mange has been the fund manager of Nippon India Nifty Pharma ETF since December 2021.
  • The ETF units are listed on both NSE and BSE.
  • Retail investors can purchase units through a demat account with a registered broker.

Investment Objective & Benchmark

  • The ETF is benchmarked against the Nifty Pharma Index Total Return Index, which tracks the top-performing companies in areas like sustainability and growth.
  • This fund's objective is to generate returns by investing in the same stocks as the Nifty Pharma Index, closely matching its performance, though some differences may occur.
  • The risk profile level of Nippon India Nifty Pharma ETF is very high.
  • The Nifty Pharma Index typically includes large-cap pharmaceutical companies which are considered more stable than smaller companies.
  • This ETF is suitable for investors looking to gain exposure to the pharmaceutical sector without having to pick individual stocks.
  • It can be a good option for those who believe in the growth potential of the Indian pharma industry.
  • The stocks in this ETF are weighted according to their proportion in the Nifty Pharma Index, based on free-float market capitalisation, which considers only the shares available for trading.
  • Companies are selected based on their market-cap ratings, focusing on those with the highest rankings in the pharma sectors. The portfolio includes a mix of large-cap and mid-cap companies that are leaders in their industries and are expected to benefit from India's growth.

Asset Allocation & Portfolio Composition

  • The ETF holds 99.68% of its fund in equity and 0.32% in cash.
  • The scheme invests in companies across market capitalisations–15.25% in giant, 33.95% in large-cap, 41.29% in mid-cap and 9.50% in small-cap.
  • The ETF's sector allocation is predominantly focused on healthcare, comprising 99.68% of the fund.
  • Top 10 Holdings of stocks are around 80.73% of this ETF’s asset allocation.

The top 10 company holdings in this ETF include:

  • Sun Pharmaceutical Industries Limited - 24.62%
  • Dr Reddy's Laboratories Limited - 10.90%
  • Cipla Limited - 10.75%
  • Divi's Laboratories Limited - 8.32%
  • Lupin Limited - 6.13%
  • Aurobindo Pharma Limited - 5.35%
  • Zydus Lifesciences Limited - 4.16%
  • Torrent Pharmaceuticals Limited - 3.85%
  • Alkem Laboratories Limited - 3.54%
  • Glenmark Pharmaceuticals Limited - 2.91%

In the last one year, the ETF has given a return of 45.6% compared to its benchmark index’s yield of 46% as of July 31, 2024.

Since its Inception, the ETF has given an annualised return of 14.68% to its investors as of July 31, 2024.

Key indicators

arrow
Tracking index
Nifty Pharma

Expense Ratio

0.21%
Tracking error
0.04%

Learn more

Investment checklist: (2/6)
arrow
check status

Liquidity

check status

Fund size

check status

Expense Ratio

check status

Tracking error

check status

Returns vs FD Rates

check status

Entry Point

The investment checklist helps you understand a company's financial health at a glance and identify quality investment opportunities easily

Returns

Returns vs Benchmark
arrow
  • ETF returns
  • Rolling returns
Compare the returns of this fund with
NIFTY 50
arrow

This ETF

Nifty 50

Please wait...

Learn more

Nippon AMC - NETF Pharma Shareholder returns

arrow
1 day
-1.03%
1 week
-0.90%
1 month
-2.24%
3 months
+3.49%
1 year
+53.01%
3 years
+64.56%
5 years
+59.56%

Nippon AMC - NETF Pharma Price history

arrow
DayOpenCloseChange %
Mon, Nov 4 2024
₹23.36
₹23.12
-1.03%
Fri, Nov 1 2024
₹23.47
₹23.36
+0.82%
Thu, Oct 31 2024
₹23.55
₹23.17
+1.44%
Wed, Oct 30 2024
₹23.33
₹22.84
-1.04%
Tue, Oct 29 2024
₹23.58
₹23.08
-1.07%
Mon, Oct 28 2024
₹23.65
₹23.33
+1.57%
Fri, Oct 25 2024
₹24.02
₹22.97
-0.04%
Thu, Oct 24 2024
₹23.55
₹22.98
+0.44%

Frequently asked questions